Concepedia
Statistics
Publications
6
Citations
327
H-Index
Active since
2003
Affiliations
Loughborough University(Current)
AstraZeneca (United Kingdom)
Steve Brough is an author at Loughborough University specializing in pharmacy, medicinal chemistry, and drug discovery.
Publications per year
2003–2015
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
Andrew Baxter, Janice Bent, Keith Bowers et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 120 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
Andrew Baxter, Steve Brough, Anne Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 91 citations
Pharmacy, Medicinal Chemistry, Pharmacology +14
Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
Andrew Baxter, Colin Bennion, Janice Bent et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 46 citations · Full text
Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists—discovery of AZD1981
Tim Luker, Roger V. Bonnert, Steve Brough et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 40 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
Investigating Scale-Up and Further Applications of DABAL-Me<sub>3</sub>Promoted Amide Synthesis
Darren S. Lee, Zacharias Amara, Martyn Poliakoff et al. · Organic Process Research & Development · 2015 · 20 citations
Pharmacy, Chemistry, Medicinal Chemistry +13
1–5 of 6